Edition:
United States

Profile: Novartis AG (NVS)

NVS on New York Consolidated

85.91USD
23 Oct 2017
Change (% chg)

$0.17 (+0.20%)
Prev Close
$85.74
Open
$86.22
Day's High
$86.59
Day's Low
$85.80
Volume
4,253,444
Avg. Vol
1,688,462
52-wk High
$86.90
52-wk Low
$66.93

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.

Company Address

Novartis AG

Lichtstrasse 35
BASEL     4056
P: +4161.3241111
F: +4161.3247826

Company Web Links